Correction to: Nature Communications https://doi.org/10.1038/s41467-024-52557-2, published online 18 September 2024

The Acknowledgements section contained an error in which individuals and work carried out at United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Walter Reed Army Institute of Research (WRAIR) and Battelle Memorial Institute were not correctly acknowledged. This has been corrected in the PDF and HTML versions of the article; the Acknowledgements section now reads:

“We thank Drs. Maria Uria Nickelson & Su Chiang, CARB-X, Boston University School of Law, Boston, USA for their valuable guidance throughout the entire period of work; Drs. Jason Cummings & Richard Slayden, Colorado State University, Fort Collins, USA for MIC determination on key biothreat pathogens; Drs. Adam Johnson, Adam Stevenson and Ana Jimenez-Valverde, University of Liverpool for assisting the mice thigh infection model studies; Drs. Maria McElmeel, Nathan Wiederhold & Thomas Patterson, The University of Texas Health Science Center at Houston, Texas, USA for MIC determination on key Gram-negative pathogens; Dr. Rafael Hernandez, Cystic Fibrosis Isolate Core, Seattle Children’s Research Institute of Seattle Children’s Hospital, Seattle, USA for MIC testing on key pathogens associated with cystic fibrosis; Dr. Ken Waites, University of Alabama at Birmingham, Birmingham, USA for MIC testing on mycoplasma strains; Dr. John Lipuma, Burkholderia cepacia Research Laboratory and Repository (BcRLR), University of Michigan Medical School, USA for MIC testing on Burkolderia species; Dr. J. Matthew Meinig & the Bacterial Therapeutics Core Branch, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA for MIC testing on key biothreat pathogens; Drs. Malik Raynor, Supaksorn Chattagul, LTC Charlotte Lanteri, Patricia Lee & the Experimental Therapeutics Branch, Walter Reed Army Institute of Research (WRAIR), USA for MIC testing on MDR pathogens from the Military Health System. MDR bacterial clinical isolates used in the WRAIR’s diversity panel testing were obtained from Military Health System beneficiaries and other individuals and provided by the WRAIR’s Multidrug-Resistant Organism and Repository and Surveillance Network (MRSN); Dr. Erin Zeituni, National Institute of Allergy and Infectious Diseases (NIAID), Rockville, USA for facilitating the MIC, in vitro DMPK and safety testing at the pre-clinical services of NIAID; Swathi Purighalla at Narayana Health for help with procuring clinical isolates. Akshaya Ravishankar, Anirudh Shanbhag, Prakruthi Amar, Purnendu Bhowmik, Purnima Singh, Rajani Ravishankar, Riya Narjari, Daljeet Kaur, Anubha Nath and Savitha Prabhumurthy, Bugworks Research India Pvt. Ltd. Bangalore, India for assisting in assays. Research reported in this manuscript is in part supported by CARB-X. CARB-X’s funding for this project is sponsored by the Cooperative Agreement Number IDSEP160030 from ASPR/BARDA and by awards from Wellcome, Germany’s Federal Ministry of Education and Research, and the UK Global Antimicrobial Resistance Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC). The content is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. This effort was funded in part by award MCDC-18-06-16-005 to Battelle Memorial Institute from MCDC, subcontracted to WRAIR. The WRAIR effort was also supported by Military Infectious Disease Research Program (MIDRP) Combatting Antibiotic Resistant Bacteria (CARB) core proposal (MI210200). Effort funded by the U.S. Government under Other Transaction number W15QKN-16-9-1002 between the MCDC and the Government. Researched reported in this manuscript was funded in part by the Defense Threat Reduction Agency with support to USAMRIID (CB10640 & CB11395). The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon. Research reported in this manuscript is in part supported by BIRAC, Dept. of Biotechnology, Govt. of India via BIPP grant BT/BIPP0803/30/14. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the U.S. Government, Battelle Memorial Institute, CARB-X or any of its funders, or BIRAC, Dept. of Biotechnology, Govt. of India.”